Dr. Rocklage joined the company, 5AM ventures, in the year 2003 as a partner and worked his way up to take the Managing Partner position one year later. The venture group is called 5AM because the company was still in its early stages of business. It is a unique name for a starting company.
Dr. Rocklage has over 30 years experience in healthcare management responsibilities which enabled the FDA to approve three of his New Drug Applications. Also, he encouraged many drug candidates to join clinical trials.
Dr. Rocklage has also contributed to the growth of Cubist Pharmaceuticals and Nycomed Salutar by serving as the Chairman and CEO. Furthermore, he once served as Board Chairman of Relypse and Novira. At the moment he serves as the Board Chairman of Rennovia, Kinestral, Cidara, and Epirus. Dr. Scott worked for Epirus Biopharmaceuticals for three months. It is vivid that Dr. Scott Rocklage has been a busy man.
He received his Bachelor’s Science degree in Chemistry from the University of California, and further advanced his studies at Massachusetts Institute of Technology. It is also at MIT that he conducted a research in the laboratory of Richard R. Schrock which awarded him a Nobel Prize in Chemistry.
Dr. Rocklage is both an inventor and co-inventor on more than 30 patents. This proves that Scott is truly a genius and a trendsetter in the chemical industry. This man has all the necessary skills required to invent or improve any chemical experiments. Dr. Scott has proven this by his thorough formal education background and training combined with all the years he has been in the healthcare fraternity.
Scott also shares ideas with other professionals. For instance, he works with scientists and business people to assist them in enriching their ideas into possible medical solutions. The learned doctor is very well organized as he manages his time wisely and prioritizes his work.
One of the things that always makes Dr. Rocklage proud is seeing his research bear fruits and saving peoples lives. An example is his research which targeted specific mutations, and the outcome was amazing since it managed to treat cancer in unparalleled ways.
To learn more, visit http://5amventures.com/team/scott-m-rocklage-phd/.